New Zealand finds itself in an increasingly isolated position among developed English-speaking nations on PFAS drinking water standards. While the United States finalized MCLs of 4 ppt for PFOA and PFOS in April 2024, Australia updated its drinking water guidelines in June 2025 to 8 ng/L for PFOS and 200 ng/L for PFOA, and the United Kingdom launched a consultation on statutory PFAS limits in 2026, New Zealand’s Drinking Water Standards—updated in November 2022—remain at levels that are dramatically higher than its peer nations and are not scheduled for revision.
Current New Zealand Standards
New Zealand’s Drinking Water Standards 2022 establish a combined maximum acceptable value (MAV) of 70 ng/L for the sum of PFHxS and PFOS, and a separate MAV of 560 ng/L for PFOA. To put these figures in context: New Zealand’s PFOA MAV is 140 times higher than the U.S. EPA’s 4 ng/L MCL, approximately 3 times higher than Australia’s revised 2025 guideline of 200 ng/L, and more than 5 times higher than the EU Drinking Water Directive’s 100 ng/L sum-of-20-PFAS parametric value. The combined PFHxS+PFOS MAV of 70 ng/L is more protective than New Zealand’s PFOA limit in relative terms, but still 17 times less stringent than the U.S. EPA’s individual MCL for PFOS.
The Regulator’s Position
New Zealand’s national water services regulator Taumata Arowai, when asked about the gap between New Zealand’s standards and those of its closest peer nations, stated that it does not automatically adopt overseas values without thorough review and adaptation to New Zealand conditions. The regulator’s official position is that its current MAVs are based on the most current risk assessment evidence available at the time they were set, and that any revision would require a comprehensive review process involving health risk assessment, economic analysis, and stakeholder consultation. No timeline for initiating such a review has been announced.
PFAS Contamination in New Zealand: Military and Airport Sources
New Zealand’s documented PFAS contamination is concentrated primarily around military airfields and civilian airports where AFFF was historically used, following the same pattern seen in Australia, the United Kingdom, and the United States. Investigation sites include RNZAF Ohakea in the Manawatū-Whanganui region, RNZAF Woodbourne near Blenheim, and Christchurch International Airport. The New Zealand Defence Force (NZDF) and the Civil Aviation Authority (CAA) have commissioned site investigations and implemented precautionary measures at affected locations, including providing alternative drinking water supplies to households with private wells affected by PFAS migration from base sites. Christchurch’s groundwater-based drinking water system—one of the purest urban water supplies in the world—has been monitored closely for PFAS, with results to date showing concentrations well below New Zealand’s current MAVs.
Public Health Advocacy and the Pressure for Review
Environmental and public health advocacy groups in New Zealand—including Environment and Conservation Organisations (ECO), the Environmental Law Initiative, and the New Zealand Medical Association—have called on Taumata Arowai to initiate a formal review of its PFAS MAVs following the publication of Australia’s updated guidelines and the U.S. EPA’s MCL finalization. Advocates argue that the significant divergence between New Zealand and its closest partners—Australia in particular, which shares similar health risk assessment frameworks and exposure contexts—cannot be justified by differences in New Zealand conditions alone, and that the public health rationale for stricter standards is as applicable to New Zealand as to Australia or the United States.
Implications for the New Zealand Water Treatment Market
The combination of permissive national standards and intense public awareness of the international standard gap is creating a consumer-driven PFAS filtration market in New Zealand that operates independently of regulatory mandates. Residents near known AFFF contamination sites are purchasing point-of-use filter systems certified to more stringent performance benchmarks—typically NSF/ANSI 53 for PFOA/PFOS reduction or NSF/ANSI 58 for reverse osmosis—based on their own risk assessment rather than regulatory requirements. Water filter retailers in New Zealand have reported significant growth in PFAS-related sales inquiries following media coverage of U.S. and Australian regulatory actions. For OEM filter manufacturers, New Zealand represents a market where consumer demand—rather than regulatory mandates—is the primary commercial driver, making product performance marketing and consumer education more important than regulatory compliance documentation in the near term.